In 2017, we initiated discovery collaborations with Roche and Lundbeck in the field of neuroscience.
We develop transformative medicines for severe diseases using our Confo® GPCR technology.
In addition to advancing our own portfolio, we are engaging in strategic partnerships with other biopharmaceutical organizations in non-competing disease areas. We have secured revenue-generating drug discovery partnerships with leading pharma companies, as well as drug discovery collaborations in support of our proprietary programs.
F. Hoffmann-La Roche Ltd
Confo Therapeutics, an emerging drug discovery company, announced today that it has entered into a research collaboration and license agreement with Roche for the discovery …
Confo Therapeutics, an emerging drug discovery company, today announced that it has entered into a drug discovery collaboration with H. Lundbeck A/S, a global pharmaceutical company …
PARTNER WITH US
As we develop our science and our pipeline, we seek to further develop our portfolio of strategic collaborations with key partners. Get in touch to discuss partnering opportunities.